ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0443910 | null | Antiproteinase 3 antibody (substance)|proteinase-3 antibody|PR-3 - Proteinase-3 antibody|Myeloblastin antibody|3 ab proteinase|p-29 antibody|Proteinase-3 antibody|Antiproteinase 3 antibody|AGP-7 antibody | Proteinase-3 antibody |
C0717758 | A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. | Etanercept (substance)|ETN|etanercept|Product containing etanercept (medicinal product)|Etanercept|Recombinant human TNF|Etanercept-containing product|TNFR:Fc|Tumor Necrosis Factor Receptor IgG Chimera|TNFR-Immunoadhesin|ETANERCEPT | etanercept |
C0021845 | Opening or penetration through the wall of the INTESTINES. | bowel perforated|Perforations, Intestinal|perforated bowel|PEFORATION BOWEL|INTESTINAL PERFORATION|Intestinal Perforations|Bowel Perforation|intestinal perforations|bowels perforated|perforation intestinal|Intestinal Perforation|Perforation of Intestine|Intestinal perforation|perforation of intestine|intestinal perforation|Perforation, Intestinal|intestine perforation|Perforation of intestine, NOS|bowel perforations|PERFORATION INTESTINAL|Perforation of intestine|Perforation of intestine (disorder)|BOWEL PERFORATION|intestines perforation|INTESTINE, PERFORATION|bowel perforation | Intestinal Perforation |
C1336776 | A transcription cofactor that activates transcription from a RNA polymerase II promoter but does not bind DNA itself. | Transcriptional Coactivator|Transcriptional Activator/Coactivator|Transcription Factor Coactivator|Transcription Activator|Transcriptional Activator | Transcription Coactivator |
C1521055 | A chromosome band present on 20q | null | 20q12 |
C0543472 | null | Studies, Outcome|outcome study|outcomes studies|Study, Outcome|outcomes study|studies outcome|outcome studies|Outcome Study | Outcome Studies |
C0279328 | Oxygen that is at an atmospheric pressure higher than the pressure at sea level. Breathing hyperbaric oxygen to enhance the effectiveness of radiation therapy is being studied. | Hyperbaric Oxygen|hyperbaric oxygen|oxygen hyperbaric | Hyperbaric Oxygen (substance) |
C0278372 | An appraisal of the operation and performance of an object of interest. | Functional Assessment|Functional assessment (procedure)|functional evaluation|evaluation functional|Functional evaluation|assessments functional|Functional assessment, NOS|assessment functional|functional assessment | Functional assessment |
C0009088 | A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) | Neuralgias, Ciliary|Histamine headache|Neuralgic Migraine|horton's headache|Cluster Headaches|Cluster Headache|HISTAMINE HEADACHE|histamine cephalgia|Cluster headache NOS|Headache Syndromes, Cluster|Headaches, Chronic Cluster|Ciliary neuralgia|Chronic Cluster Headaches|Cluster headache syndrome (disorder)|headaches histamine|Syndrome, Horton|Cluster Headache Syndrome|Histamine Cephalgia|Ciliary neuralgia (finding)|Ciliary Neuralgias|cluster headaches|HEADACHE HISTAMINE|horton syndrome|CEPHALALGIA, PAROXYSMAL, NOCTURNAL, ORBITAL|Vasomotor headache|Migrainous neuralgia|CLUSTER HEADACHES|ERYTHROPROSOPALGIA|Cephalgias, Histamine|Histamine Cephalgias|migrainous neuralgia|Hortons Syndrome|headaches cluster|histamine headache|Horton's headache|chronic cluster headaches|Cluster headache syndrome|HEADACHE VASOMOTOR|Horton's Syndrome|Chronic cluster headache|Migraine, Neuralgic|horton's syndrome|horton's neuralgia|hortons syndrome|Cluster Headache, Chronic|Cluster headache|cluster headache syndrome|Chronic Cluster Headache|clusters headache|Cluster Headache Syndromes|Neuralgic Migraines|cluster headache|BING-HORTON SYNDROME|Histamine cephalgia|Headache, Chronic Cluster|Horton Syndrome|headache histamine|Syndromes, Cluster Headache|Neuralgic migraine|Syndrome, Cluster Headache|Headaches, Cluster|Syndrome, Horton's|CEPHALALGIA, HISTAMINE|Cluster Headaches, Chronic|Chronic cluster headache (disorder)|Headache, Cluster|Ciliary Neuralgia|Neuralgia, Ciliary|HORTON'S HEADACHE|HORTON SYNDROME|CLUSTER HEADACHE|Cephalgia, Histamine|headache cluster|chronic cluster headache|Horton's neuralgia|Headache Syndrome, Cluster|Migraines, Neuralgic|Cluster headache syndrome, unspecified | Cluster Headache |
C0535025 | A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigraine effect. | Serotonin 1Dbeta Receptors|Serotonin 1Dbeta Receptor|5-Hydroxytryptamine 1B Receptors|Receptor, Serotonin 1Dbeta|Receptor, Serotonin 1B|5 Hydroxytryptamine 1B Receptor|Receptor, 5-Hydroxytryptamine 1B|5 Hydroxytryptamine 1B Receptors|5 HT1Dbeta Receptor|Receptors, 5-Hydroxytryptamine 1B|5-HT1B Receptor|Receptor, 5-HT1Dbeta|1B Receptors, 5-Hydroxytryptamine|Receptors, Serotonin 1Dbeta|Serotonin 1D Beta Receptor|Receptor, 5 Hydroxytryptamine 1B|5-HT(1B) Receptor|1B Receptor, 5-Hydroxytryptamine|5 HT1B Receptor|Serotonin 1B Receptor|5-HT(1Dbeta) Receptor|5-HT1Dbeta Receptor|Receptor, 5-HT1B|Receptor, Serotonin Type 1Dbeta|5-Hydroxytryptamine 1B Receptor | Receptor, Serotonin, 5-HT1B |
C0239888 | null | headaches recurrent|recurrent headache|headache recurrent|HEADACHE, RECURRENT|Headaches, recurrent|Recurrent headaches | Headache recurrent |
C1579373 | null | null | Drugs used for the treatment of acute migraine |
C0017710 | A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. | GLUCOCORTICOIDS|Glucocorticoid|Product containing glucocorticoid (product)|Glucocorticoid hormone (substance)|Therapeutic Glucocorticoid|glucocorticoids|Glucocorticoid hormone|glucocorticoid hormone|Glucocorticoids|Glucocorticoid-containing product|glucocorticoid hormones|glucocorticoid|glucocorticoids hormone|Glucocorticoid (substance) | Glucocorticoids |
C0678897 | neuroendocrine system of neurons, fiber tracts, endocrine tissue, and blood vessels which produces and releases pituitary hormones into the systemic circulation. | hypothalamic pituitary axis|axis hypothalamic pituitary|hypothalamus-pituitary axis|hypothalamus hypophysis axis|axis hypothalamus pituitary | hypothalamic pituitary axis |
C0001622 | Abnormally high level of cortisol in the blood. | Overproduction of ACTH|adrenal cortical hyperfunction|HYPERADRENOCORTICISM|Hyperfunction, Adrenal Gland|hyperadrenocorticism|adrenal gland hyperfunction|Hypercortisolemia|adrenal cortex hyperfunction|Hypercorticism|cortisol overproduction|adrenocortical hyperfunction|Adrenocortical hyperfunction (disorder)|Disorder of corticoadrenal overactivity|HYPERCORTICISM ADRENAL|Suprarenogenic syndrome|Hyperfunction, Adrenocortical|Adrenocortical Hyperfunction|hypercortisolism|Hypercortisolism|hypercortisolemia|overproduction of cortisol|HYPERADRENALISM|Overproduction of cortisol|Adrenal Gland Hyperfunction|Adrenocortical hyperactivity syndrome|HYPERCORTISONISM|Hypercortisolism (disorder)|hyperadrenalism|hypercorticism|ADRENAL CORTEX HYPERFUNCTION|Hyperadrenocorticism|Hyperadrenalism|ADRENAL HYPERCORTICISM|Adrenocortical hyperfunction | Adrenal Gland Hyperfunction |
C1278928 | null | Entire biliary tract (body structure)|Entire biliary tract | Entire biliary tract |
C0045093 | A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA. This locks DNA polymerase thereby resulting in "masked termination" during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA. | 2',2'-difluorodeoxycytidine|1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose|Difluorodeoxycytidine|GEMCITABINE|Gemcitabina|2',2'-DFDC|Gemcitabin|Product containing gemcitabine (medicinal product)|Gemcitabine-containing product|gemcitabine|Gemcitabine|dFdC|Gemcitabinum|2'Deoxy-2',2'-Difluorocytidine|2,2 difluorodexoycytidine|2',2'-Difluorodeoxycytidine|2'-Deoxy-2',2'-difluorocytidine|2',2'-difluoro-2'-deoxycytidine|dFdCyd|4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabine (substance)|2'-deoxy-2'-difluorocytidine | gemcitabine |
C0008340 | A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common. | Choledochal Cyst|Choledochal Cysts|Congenital choledochal cyst (disorder)|CHOLEDOCHAL CYSTS|Bile Duct Cysts|BILE DUCT, COMMON, CYSTIC DILATATION|Choledochal cyst|Cystic dilatation of common bile duct (disorder)|Cyst, Bile Duct|Congenital biliary duct cyst|Choledochoceles|BILE DUCT CYSTS|choledochocoele|Congenital cystic dilatation of common bile duct|Congenital common duct cyst|Bile Duct Cyst|CHOLEDOCHOCELE|Duct Cyst, Bile|Choledochocoele|cyst choledochal|Congenital choledochal cyst|choledochocyst|choledochal cyst|choledochocele|Choledochocele (disorder)|Choledochocele|Cyst, Choledochal|Cystic dilatation of common bile duct|Choledochal Cyst, Congenital|Cyst, Congenital Choledochal|CHOLEDOCHUS, CYST|Choledochocyst|choledochal cysts|Cyst of the ductus choledochus|Congenital Choledochal Cysts|choledochus cyst|Congenital Choledochal Cyst | Choledochal Cyst |
C0015250 | The surgical removal of an entire structure or organ. | Incision and removal, complete|Complete excision|Total Resection|Complete Excision|Excision, complete|Complete excision of organ|Complete excision of organ (procedure)|Complete Resection|Complete incision and removal | Complete excision |
C0149631 | null | bile reflux gastritis|Biliary gastritis|Bile-induced gastritis (disorder)|BILE REFLUX GASTRITIS|bile induced gastritis|GASTRITIS, BILE ACID REFLUX|GASTRITIS, BILIARY|GASTRITIS, BILE REFLUX|Alkaline reflux gastritis|biliary gastritis|Bile induced gastritis|Bile reflux gastritis|Bile-induced gastritis|alkaline reflux gastritis | Bile-induced gastritis |
C0701818 | Presence or formation of GALLSTONES in the COMMON BILE DUCT. | CHOLEDOCHOLITHIASIS|choledocholithiasis|Choledocholithiasis|Cholelithiasis, Common Bile Duct | Choledocholithiasis |
C1150110 | OBSOLETE. Catalysis of the intramembrane proteolysis of a signal peptide, following its removal from a preprotein. [PMID:12077416] | null | signal peptide peptidase activity |
C0008310 | Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure. | Endoscopic Retrograde Cholangiopancreatography|Endoscopic retrograde cholangiopancreatography, NOS|ERP|Endoscopic retrograde cholangiopancreatography [ERCP]|Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct (procedure)|Cholangiopancreatography, Endoscopic Retrograde|Endoscopic catheterization of pancreatic duct and bile duct systems (procedure)|Cholangiopancreatographies, Endoscopic Retrograde|endoscopic retrograde cholangiopancreatography (ERCP)|Endoscopic catheterization of pancreatic duct and bile duct systems|Endoscopic retrograde cholangio-pancreatography|Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct|Endoscopic retrograde cholangiopancreatography|Endoscopic Retrograde Cholangiopancreatographies|endoscopic retrograde cholangiopancreatography|ERCP, NOS|Endoscopic retrograde choledochopancreatography|Endoscopic catheterisation of pancreatic duct and bile duct systems|ERCP|Retrograde Cholangiopancreatography, Endoscopic|ERCP (endoscopic retrograde cholangiopancreatography)|Retrograde Cholangiopancreatographies, Endoscopic|ERCP - Endoscopic retrograde cholangiopancreatography|Endoscopic retrograde cholangiopancreatography (procedure) | Endoscopic Retrograde Cholangiopancreatography |
C0948386 | null | null | biliary sphincterotomy |
C1280323 | null | Entire cystic duct|Entire cystic duct (body structure) | Entire cystic duct |
C0267869 | null | biliaris calculus|calculus of bile duct|Bile Duct Stone|calculi biliary|Calculus of bile duct, NOS|biliary stones|biliary calculus|biliary stone|bile ducts stones|Bile Duct Calculus|bile duct stones|Calculus of bile duct|bile duct stone|Calculus of bile duct (disorder)|biliary calculi|Bile ducts stone | Bile duct calculus |
C0005424 | Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER. | BILIARY TRACT DISEASE, NOS|Disorder of biliary tract (disorder)|Biliary Tract Disease|Disease of biliary tract, NOS|Tract Disease, Biliary|biliary and gallbladder disorder|biliary disease tract|biliary tract disorder|Diseases, Biliary Tract|Biliary tract disease|Biliary tract--Diseases|Biliary Tract Diseases|Disease, Biliary Tract|biliary tract disorders|Hepatobiliary tract disease|Disorder of biliary tract|Unspecified disorder of biliary tract|Disease of biliary system|biliary tract disease|biliary tract diseases|Tract Diseases, Biliary | Biliary Tract Diseases |
C0745744 | A disorder characterized by irreversible damage to the liver tissue, leading to complete liver failure. Causes include cirrhosis, viral hepatitis, metastases to the liver, genetic disorders, toxins, and drugs. | disease end liver stage|End-Stage Liver Disease|Chronic Liver Failure|End stage liver disease|disease end liver stages|liver disease end stage|End Stage Liver Disease (Decompensated Liver Disease)|end stage liver disease|End stage liver disease (disorder)|End Stage Liver Disease | End Stage Liver Disease |
C0016977 | Diseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases. | gall bladder disorder|Disease of gallbladder, NOS|gallbladder disease|Gall Bladder Disease|GALL BLADDER DISORDER|Unspecified disorder of gallbladder|Gallbladder disease|biliary disease|Disease, Gall Bladder|disease biliary|Gallbladder disorder, NOS|gallbladder diseases|Disease, Gallbladder|gall bladder diseases|gall bladder disease|Gall Bladder Diseases|Disorder of gallbladder (disorder)|Diseases and Syndromes of Gallbladder|Gallbladder--Diseases|DISEASE GALLBLADDER|Diseases, Gallbladder|Gallbladder Diseases|Bladder Diseases, Gall|biliary diseases|Gallbladder Disorder|Disease of gallbladder|Gall Bladder Disorder|Gallbladder Disease|Disorder of gallbladder|Bladder Disease, Gall|gallbladder disorders|Gallbladder disorder|Diseases, Gall Bladder|gallbladder disorder | Gall Bladder Diseases |
C0008313 | Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS. | Cholangiitides, Sclerosing|CHOLANGITIS, FIBROSING|Sclerosing Cholangiitides|Sclerosing cholangitis|chronic obliterative cholangitis|CHOLANGITIS, OBLITERATIVE, CHRONIC|sclerosing cholangiitis|sclerosing cholangitis|Fibrous cholangitis|Cholangiitis, Sclerosing|CHOLANGITIS SCLEROSING|Cholangitides, Sclerosing|Sclerosing Cholangitis|Sclerosing Cholangiitis|SCLEROSING CHOLANGITIS|Sclerosing Cholangitides|fibrosing cholangitis|Cholangitis, Sclerosing|Sclerosing cholangitis (disorder) | Cholangitis, Sclerosing |
C0206698 | A malignant tumor arising from the epithelium of the BILE DUCTS. | cholangiocarcinoma|Cholangiocellular carcinoma|Cholangiocarcinoma of biliary tract (disorder)|Cholangiocarcinomas|Cholangiocarcinoma of biliary tract|CHOLANGIOCARCINOMA, MALIGNANT|Cholangiocarcinoma, intrahepatic and extrahepatic bile ducts (adenocarcinoma)|Intrahepatic Bile Duct Cancer (Cholangiocarcinoma)|Cholangiocarcinoma|Carcinomas, Cholangiocellular|Bile duct cancer|Cholangiocarcinoma (morphologic abnormality)|cholangiocellular carcinoma|Cholangiocellular Carcinomas|Carcinoma, Cholangiocellular|Cholangiocellular Carcinoma|CC|cholangiosarcoma|Cholangiocar.- intra/extrahepatic|cholangiocarcinomas | Cholangiocarcinoma |
C0033972 | The use of more than one therapist at one time in individual or group psychotherapy. | Multiple therapy|cotherapy|Psychotherapies, Multiple|Multiple Psychotherapies|Dual leadership therapy|Combined therapy (regime/therapy)|multiple psychotherapy|combined therapy|cooperative therapy|Three cornered therapy|Cooperative therapy|Co-therapy|Group co-therapy|Combined therapy, NOS|multiple therapy|Combined therapy|Multiple psychotherapy|Multiple Psychotherapy | Psychotherapy, Multiple |
C0013395 | Impaired digestion, especially after eating. | dyspepsia|Dyspepsia|Dyspepsias|Indigestion|Indigestion (finding)|Indigestions|INDIGESTION|Dyspepsia, NOS|Indigestion, NOS|DYSPEPSIA|indigestion | Dyspepsia |
C0030920 | Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). | Peptic ulcer; site unspecified|Ulcers, Peptic|Ulcers, Gastroduodenal|PEPTIC ULCER|Ulcer disease|ULCER PEPTIC|Gastroduodenal Ulcer|PEPTIC ULCER DISEASE|peptic ulcer disorder|Peptic Ulcers|Ulcer, Gastroduodenal|ulcer of the gastrointestinal tract|Ulcer, Peptic|ULCER GASTRODUODENAL|Peptic ulcer disease|Peptic ulcer, site unspecified|ULCER SYNDROME PEPTIC|Gastroduodenal Ulcers|PUD - Peptic ulcer disease|Peptic ulceration|pud|Sore in the lining of gastrointestinal tract|Peptic ulcer|Gastroduodenal ulcer|Ulcer, peptic|Gastroduodenal ulcer, NOS|SYNDROME PEPTIC ULCER|PU - Peptic ulcer|Peptic ulcer, NOS|Peptic ulcer (disorder)|peptic ulcer|peptic ulcers|gastroduodenal ulcer|peptic ulcer disease|peptic ulcer nos|PEPTIC ULCER SYNDROME|Peptic Ulcer|Peptic Ulcer Disease | Peptic Ulcer |
C0151785 | null | Mucosal disease, NOS|MUCOUS MEMBRANE DISORDER|Disease of mucosa|membrane mucous|mucosa disease|MUCOUS MEMBRANE|Mucous membrane disorder|MUCOUS MEMBRANE DISORDER (NOS)|MEMBRANE MUCOUS DISORDER (NOS)|disorders membrane mucous|Mucous membrane disorder, NOS|mucosal disease|Disease of mucosa, NOS|DISEASES OF THE MUCOUS MEMBRANES|diseases mucosal|Disease of mucous membrane, NOS|Disorder of mucous membrane|Disorder of mucous membrane (disorder)|Mucosal disease | Disease of mucous membrane |
C0456388 | Any natural or synthetic composition that replicates the structure or function of a native component of blood. | blood products|Blood replenisher, NOS|Blood Product|blood product|BLOOD REPLENISHERS|Blood product|Blood Replenishers|Blood product (product)|Blood replenisher | Blood product |
C0028900 | Visits made by patients to health service providers' offices for diagnosis, treatment, and follow-up. | office visits|Office Visit|office visit|Visit, office|Visit, Office|Visits, Office | Office Visits |
C0206658 | A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle. | Smooth Muscle Tumor|Smooth muscle tumour of uncertain malignant potential|Smooth Muscle Neoplasm|Smooth muscle tumor (morphologic abnormality)|Neoplasm of Smooth Muscle|Smooth muscle tumor|smooth muscle tumor|Smooth muscle tumour|Tumor of the Smooth Muscle|Tumor of Smooth Muscle|Smooth muscle tumors|Tumor, Smooth Muscle|Smooth muscle tumor of uncertain malignant potential|muscle smooth tumor|Smooth muscle tumor, NOS|Smooth muscle--Tumors|Smooth muscle tumour, NOS|Muscle Tumor, Smooth|Neoplasm of the Smooth Muscle|Tumors, Smooth Muscle|smooth muscle tumors|Smooth Muscle Tumors|Muscle Tumors, Smooth | Smooth Muscle Tumor |
C0220704 | caused by microdeletion on chromosome 22q11.2; associated with multiple congenital anomalies, learning disabilities, behavioral phenotypes including ADHD and anxiety, with schizophrenic risk in adulthood. | Syndrome, Velo-Cardio-Facial|Sedlackova Syndrome|syndromes velocardiofacial|Chromosome 22q11.2 deletion syndrome|Velo-Cardio-Facial Syndrome|shprintzens syndrome|Velo-cardio-facial syndrome|CHROMOSOME 22q11.2 DELETION SYNDROME|shprintzen syndrome|VCF SYNDROME|Velo Cardio Facial Syndrome|Shprintzen syndrome|Shprintzen VCF Syndrome|velo-cardio-facial syndrome|VELOCARDIOFACIAL SYNDROME|Deletion Syndrome, 22q11.2|Syndrome, Sedlackova|Deletion 22q11.2 Syndrome|Deletion 22q11.2 syndrome|VCF Syndrome|SHPRINTZEN VCF SYNDROME|velocardiofacial syndrome|Syndrome, Shprintzen|Shprintzen Syndrome|Velocardiofacial Syndrome|VCFS|22q11.2 Deletion Syndrome|Syndrome, Velocardiofacial|Syndrome, VCF|22q11.2DS | Shprintzen syndrome |
C0086640 | null | Psychotic Mood Disorder|Mood Disorder, Psychotic|Mood Disorders, Psychotic | Psychotic Mood Disorders |
C0005119 | Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness. | Bereavement reaction|bereavement|Bereavements|Bereavement | Bereavement |
C0076829 | A sulfamate-substituted monosaccharide with anticonvulsant property. Although the mechanism of action has not been fully elucidated, topiramate antagonizes kainate/AMPA subtype of the glutamate receptors, which are ligand-activated cation channels that mediate the fast component of excitatory postsynaptic currents in neurons of the central nervous system. This antagonistic action results in stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses, thereby impedes seizure occurrences. In addition, this agent augments gamma-aminobenzoic acid (GABA) activity and thereby attenuating GABAnergic inhibitory transmission. | TOPIRAMATE|Topiramate|Topiramate (substance)|2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Tipiramate|Topiramato|Topiramatum|topiramate|2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate|TPM|Topiramate-containing product|Tipiramato|beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, Sulfamate|beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate|Product containing topiramate (medicinal product)|2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate | topiramate |
C0086133 | null | Syndromes, Depressive|Syndrome, Depressive|depressive syndrome|Depressive Syndromes | Depressive Syndrome |
C0012772 | A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase. | Disulfiram-containing product|disulphiram|TTD|Tetraethylthiuram Disulfide|N,N,N',N'-tetraethylthiuram disulfide|Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetraethyl-|Tetraethylthioperoxydicarbonic diamide|Bis(diethylthiocarbamoyl) Disulfide|bis(diethylthiocarbamoyl) disulfide|tetraethylthioperoxydicarbonic diamide|tetraethylthiuram disulfide|DISULFIRAM|Disulfiram (substance)|Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2|Disulfiram|Product containing disulfiram (medicinal product)|Tetraethylthiuram disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|DS|Tetraethylthioperoxydicarbonic Diamide|disulfiram|Disulfide, Tetraethylthiuram|Tetraethylthiuram disulfide | disulfiram |
C0460149 | null | peroneal tendon|Peroneal tendon (body structure)|peroneal tendons | Peroneal tendon |
C0972337 | null | null | Hexavac |
C0008049 | A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) | Chicken Pox Infection|varicella infection|Varicella (disorder)|CHICKEN POX|chicken pox|varicella|Chicken Pox|Varicella|Varicella NOS|Chicken pox|Chickenpox, NOS|Varicella, NOS|Chickenpox NOS|VARICELLA|Chickenpox|Varicella infection|chickenpox|CHICKENPOX | Chickenpox |
C0022354 | Jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS. | JAUNDICE, CHOLESTATIC|jaundice cholestatic|jaundice obstructive|Cholestatic jaundice syndrome, NOS|Obstructive jaundice|Cholestatic jaundice, NOS|Jaundice, Mechanical|obstructive jaundice|JAUNDICE, REGURGITATION|JAUNDICE, OBSTRUCTIVE|Cholestatic jaundice syndrome|Obstructive hyperbilirubinemia (disorder)|JAUNDICE CHOLESTATIC|cholestatic jaundice|Cholestatic jaundice|Cholestatic Jaundice|Jaundice, Obstructive|Obstructive hyperbilirubinemia|CHOLESTATIC JAUNDICE|cholestatic icterus|Jaundice, Cholestatic|Obstructive Jaundice|Obstructive hyperbilirubinaemia|Cholestatic jaundice syndrome (disorder)|Mechanical Jaundice|Jaundice, obstructive | Jaundice, Obstructive |
C0700502 | Hypothyroidism, the cause of which is not present at birth. | Acquired hypothyroidism, NOS|Acquired hypothyroidism (disorder)|Hypothyroidism, primary or NOS|Acquired hypothyroidism|Primary hypothyroidism|Acquired Hypothyroidism | Acquired hypothyroidism |
C0455913 | null | large testicle|enlarged testicles|testicle enlarged|Enlarged testicle|enlarged testicle|Large testicle|enlargement testicles|testicle large|enlargement testicle|testicle enlargement|large testicles|Large testicle (finding) | Large testicle |
C0344307 | Inability to perceive painful stimuli. [HPO:probinson] | Insensitivity to pain|Pain insensitivity|No sensitivity to pain (finding)|ANALGESIA|pain anesthesia|analgesia|Absence of sensibility to pain|Analgesia|Absence of pain sensation|Anesthesia to pain|absence of pain sensation|Feels no pain|Anaesthesia to pain|No sensitivity to pain | Absence of pain sensation |
C0014038 | Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. | brain inflammation|encephalitis|Inflammation, Brain|inflammation of the brain|Brain Inflammations|Encephalitis, NOS|Encephalitis|Encephalitis (disorder)|Brain Inflammation|ENCEPHALITIS|Brain inflammation | Encephalitis |
C0234421 | Sense of awareness of self and of the environment. | conscious|Consciousnesses|Conscious|Conscious State|State of awareness|consciousness|CONSCIOUS|Consciousness, NOS|Consciousness | Conscious |
C0020587 | Therapeutic intervention in which a person is induced through clinical guidance into a hypnotic state. | clinical hypnosis|Hypnotherapy|Hypnosis for therapy|Mental Health @ None @ Hypnosis @ None @ None @ None @ None|Hypnosis for therapy (regime/therapy)|Hypnotism|Hypnotherapy (regime/therapy)|hypnotherapy|Hypnotherapies|Hypnosis|Mesmerism|hypnosis|Clinical Hypnosis | Hypnotherapy |
C0042291 | A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. | acidum valproicum|dipropylacetic acid|VA|Pentanoic acid, 2-propyl-|4-heptanecarboxylic acid|valproic acid|Di-n-propylacetic Acid|dipropylacetic acid (DPA)|Valproic acid (substance)|2-propylvaleric acid|DIVALPROEX|VALPROIC ACID|Divalproex|2-Propylvaleric acid|dpa|divalproex|Di-n-propylessigsäure|DPA - dipropylacetic acid|2-Propylvaleric Acid|Valproic acid|acide valproque|2-propyl-pentanoic acid|di-n-propylacetic acid|n-DPA|Valproic Acid|2 Propylpentanoic Acid|Product containing valproic acid (medicinal product)|2-Propylpentanoic Acid|2-propylpentanoic acid|Valproic acid-containing product|VPA|ácido valproico|DPA|Dipropylacetic acid|2-Propylpentanoic acid|Propylisopropylacetic Acid|2-n-propyl-n-valeric acid|Valproinsäure | valproic acid |
C0025295 | An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111) | Streptococcus pneumoniae Meningitides|Pneumococcal meningitis (disorder)|meningitis pneumococcal|Pneumococcal Meningitides|Meningitis, Streptococcus pneumoniae|pneumococcal meningitis|Streptococcus pneumoniae Meningitis|Meningitides, Streptococcus pneumoniae|PNEUMOCOCCAL MENINGITIS|Pneumococcal meningitis|Pneumococcal Meningitis|MENINGITIS, PNEUMOCOCCAL | Meningitis, Pneumococcal |
C0025299 | Protrusion of the meninges through a defect of the vertebral column. [HPO:sdoelken] | meningoceles|Meningocele|meningocele|Meningocele (disorder) | Meningocele |
C0007165 | The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). | Outputs, Cardiac|Cardiac output|Cardiac output (observable entity)|cardiac output|Output, Cardiac|heart output|Cardiac Output|CO - Cardiac output|CARDOUT|Cardiac Outputs|Cardiac output, NOS | Cardiac Output |
C1266119 | Rare neoplasms of mesenchymal origin, usually benign, and most commonly involving the PLEURA (see SOLITARY FIBROUS TUMOR, PLEURAL). They also are found in extrapleural sites. | solitary fibrous tumor|Fibrous Tumors, Solitary|Localized fibrous tumor|Solitary fibrous tumour|Tumor, Solitary Fibrous|Solitary fibrous tumor (morphologic abnormality)|solitary fibrous tumour|Localised fibrous tumour|SFT|Localized Fibrous Tumor|Fibrous Tumor, Solitary|Solitary Fibrous Tumor|Tumors, Solitary Fibrous|Solitary fibrous tumor|Solitary Fibrous Tumors | Solitary fibrous tumor |
C0230193 | The anterior abdominal wall constitutes a hexagonal area defined superiorly by the costal margins and xiphoid process; and inferiorly by the iliac crests, inguinal ligament, pubis and pubic symphysis. The wall extends posteriorly and incorporates the lateral aspect of the wall until the junction with the posterior abdominal wall approximately at the mid-axillary line. The wall is covered externally by skin and subcutaneous tissue: beneath this lies the superficial fascia (between the dermis and the muscles), which is conventionally divided into a superficial fatty layer (Camper's fascia) and a deep membranous layer (Scarpa's fascia); deep fascia; the rectus abdominis, pyramidalis, external oblique, internal oblique and transversus abdominis; and the extraperitoneal tissue and the parietal peritoneum. These tissues also form the umbilicus and the inguinal canal, which connects the abdominal cavity to the scrotum in males and the labia majora in females. | Ventral abdominal wall structure|Anterior abdominal wall|Anterior abdominal wall structure|Anterior abdominal wall structure (body structure) | Anterior abdominal wall |
C0037747 | Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. | SPAIN|ESP|spain|ES|Spain (geographic location)|Spain | Spain |
C0030551 | Persons functioning as natural, adoptive, or substitute parents. The heading includes the concept of parenthood as well as preparation for becoming a parent. | Parents|PARENT|Parent of|of parent|parent|parents|Parent of (observable entity)|Parental|Parent, NOS|Parent (person)|Parent | parent |
C1258064 | Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual. | Uses, Therapeutic|therapeutic uses | Therapeutic Uses |
C0033414 | Encouragement of the progress or growth or acceptance of something. | Promote|promotions|Promotion|promotion|Promoting|Promotion (procedure) | Promotion (action) |
C0424000 | Thoughts of taking one's own life. | ideation suicidal|Suicidal Thought(s)|Suicidal Ideation|Ideations, Suicidal|Suicidal ideation|Suicidal Ideations|ideations suicidal|suicidal thoughts|Feeling suicidal|thoughts about suicide|suicidal ideation|Feeling suicidal (finding)|Suicidal thoughts|suicide thoughts|Ideation, Suicidal|Suicidal thoughts (finding) | Feeling suicidal (finding) |
C0029341 | A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS. | Family Orthomyxoviridae|orthomyxovirus|Orthomyxovirus group, NOS|influenza virus|Orthomyxoviruses|virus influenza|Orthomyxovirus|Influenza Viruses|Influenza Virus|Influenzavirus group, NOS|Orthomyxovirus group|ORTHOMYXOVIRUS GROUP|Influenzavirus, NOS|Influenzavirus group|Influenza viruses|orthomyxoviridae|influenzavirus|Influenza virus|Family Orthomyxoviridae (organism)|Orthomyxoviridae|Influenza group viruses | Orthomyxoviridae |
C0231749 | An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the knee. [UToronto:chum] | knee pain|PAIN KNEE|aching knee|Arthralgia (knee)|Knee pain (finding)|Knee(s) Pain|gonalgia|knee joint pain|Gonalgia|Arthralgias (knees)|Knee joint pain|knee arthralgia|pain in knee|KNEE PAIN|knee pains|Knee arthralgia|painful knee|Pain in the knees|Arthralgia of knee|Knee pain|knees aching|aching knees | Knee pain |
C0448170 | null | Entire iliac spine|Entire iliac spine (body structure) | Entire iliac spine |
C1521714 | null | Uterus - Cervix (MMHCC)|Mouse Cervix Uteri | Uterus - Cervix (MMHCC) |
C0854532 | null | myopericarditis|Myopericarditis (disorder) | Myopericarditis |
C1134535 | A radiolabeled monoclonal antibody that is used to treat certain types of B-cell non-Hodgkin lymphoma and is being studied in the treatment of other types of B-cell tumors. It is made up of the monoclonal antibody ibritumomab plus the radioisotope yttrium Y 90. It binds to the protein called CD20, which is found on B cells. The radiation in the yttrium Y 90 may kill the cancer cells. Y 90 ibritumomab tiuxetan is a type of radiopharmaceutical. | Y 90 ibritumomab tiuxetan|ibritumomab tiuxetan (90Y)|90Y ibritumomab tiuxetan|yttrium Y90 ibritumomab tiuxetan|Yttrium Y-90 Ibritumomab Tiuxetan|YTTRIUM Y-90 IBRITUMOMAB TIUXETAN|Yttrium Y 90 Ibritumomab Tiuxetan|Y 90 Ibritumomab Tiuxetan|Y 90 Zevalin|yttrium Y 90 ibritumomab tiuxetan | yttrium-90-ibritumomab tiuxetan |
C1299433 | null | Left main coronary artery disease (disorder) | Left main coronary artery disease |
C0199640 | null | Cardiac pacing, NOS|Electrical cardiac pacing|Cardiac pacing|CARDIAC PACING PROCEDURES|cardiac pace|cardiac pacing|Cardiac pacing (procedure) | Cardiac pacing |
C1279380 | null | Entire transplanted heart (body structure)|Entire transplanted heart | Entire transplanted heart |
C1121571 | null | Paraoxonase-1|Paraoxonase 1 | Paraoxonase 1 |
C1336344 | Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) | Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Laryngeal Verrucous Carcinoma|Stage IVA Laryngeal Verrucous Carcinoma AJCC v7|Stage IVA Larynx Verrucous Carcinoma|Stage IVA Verrucous Carcinoma of Larynx|Stage IVA Laryngeal Throat Verrucous Cancer | Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 |
C1336344 | Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) | Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Laryngeal Verrucous Carcinoma|Stage IVA Laryngeal Verrucous Carcinoma AJCC v7|Stage IVA Larynx Verrucous Carcinoma|Stage IVA Verrucous Carcinoma of Larynx|Stage IVA Laryngeal Throat Verrucous Cancer | Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 |
C1121571 | null | Paraoxonase-1|Paraoxonase 1 | Paraoxonase 1 |
C0031545 | Radiographic visualization or recording of a vein after the injection of contrast medium. | Phlebographies|Venogram|Venographies|Phlebography, NOS|Venography (procedure)|Phlebogram, NOS|Phlebography|venogram|Venography, NOS|phlebography|Phlebogram|venograph|venograms|Venography|venography|Venogram, NOS | Venography - procedure |
C1112343 | null | Obstruction of iliac vein (disorder)|Obstruction of iliac vein|Occlusion of iliac vein (disorder) | Occlusion of iliac vein |
C0020889 | The largest of three bones that make up each half of the pelvic girdle. | Bone structure of ilium (body structure)|Os ilium|ILIUM|Bone structure of ilium|Iliac|Iliums|Os iliacum|BONE, ILIUM|ilium|Ilium, NOS|Ilium|Os ilii|Iliac bone | Bone structure of ilium |
C0026266 | Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. | Mitral valve insufficiency|mitral valve incompetence|Mitral Insufficiency|MITRAL INSUFFICIENCY|Mitral valve regurgitation, NOS|Mitral Incompetence|mrs|Mitral regurgitation, NOS|Regurgitation, Mitral Valve|Mitral valve incompetence, NOS|MITRAL VALVE, INCOMPETENCY|Mitral Valve Regurgitation|MR - Mitral regurgitation|mr|Incompetence, Mitral Valve|mitral valve regurgitation|Mitral Valve Incompetence|mitral valve insufficiency|MI - Mitral incompetence|Insufficiency, Mitral|MITRAL VALVE REGURGITATION|Incompetence, Mitral|Valve Regurgitation, Mitral|Insufficiency, Mitral Valve|mitral insufficiency|Mitral regurgitation|Mitral Regurgitation|Mitral valve regurgitation|Regurgitation, Mitral|mitral incompetence|MITRAL VALVE INSUFFICIENCY|mitral regurgitation (MR)|Mitral insufficiency|Mitral incompetence|Mitral valve incompetence|Valve Incompetence, Mitral|Mitral Valve Insufficiency|Valve Insufficiency, Mitral|mitral regurgitations|Mitral valve regurgitation (disorder)|MITRAL REGURGITATION|mitral regurgitation|Mitral valve insufficiency, NOS | Mitral Valve Insufficiency |
C1305766 | null | Entire outflow tract of left ventricle (body structure)|Entire LVOT - Left ventricular outflow tract|Entire left ventricular outflow tract|Entire outflow tract of left ventricle | Entire outflow tract of left ventricle |
C1299557 | null | Dynamic obstruction (morphologic abnormality) | Dynamic obstruction |
C0033860 | A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. | Psoriases|psoriasis|psoriases|psoriasi|PSORIASIS|Psoriasis|Psoriasis (disorder)|Psoriasis, NOS | Psoriasis |
C1531518 | null | Biological treatment (regime/therapy) | Biological treatment |
C0027030 | The invasion of living tissues of man and other mammals by dipterous larvae. | Infestation caused by maggots|myiases|MAGGOT INFESTATION|Myiasis - fly larvae infestation|infestation maggot|Infestation by maggots|Myiasis|Infestation, Maggot|Maggot Infestation|Infestation by fly larvae|myiasis|MYIASIS|Myiases|Infestation caused by fly larvae (disorder)|Maggot Infestations|Infestation by fly larvae, NOS|Fly larva infestation|Infestations, Maggot|Infestation caused by fly larvae|maggot infestation|Myiasis, NOS | Myiasis |
C0595989 | Cancer that forms in tissues of the larynx (area of the throat that contains the vocal cords and is used for breathing, swallowing, and talking). Most laryngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the larynx). | Laryngeal Carcinoma|Carcinoma of Larynx|Carcinoma of the Larynx|Laryngeal carcinoma|carcinoma laryngeal|Cancer of the larynx|Laryngeal Throat Cancer|carcinoma larynx|laryngeal carcinoma|CARCINOMA OF LARYNX|Carcinoma of larynx|Larynx Carcinoma|Cancer of the Larynx|LARYNGEAL CARCINOMA|carcinoma of larynx|larynx carcinoma|Carcinoma of larynx (disorder)|Laryngeal Cancer|laryngeal cancer|CARCINOMA LARYNX|LARNYX CARCINOMA|Cancer of Larynx|Larynx Cancer|Laryngeal cancer | Carcinoma of larynx |
C0037286 | Tumors or cancer of the SKIN. | tumor skin|Neoplasm of skin (disorder)|cutaneous tumor|Tumor of the skin|cutaneous tumors|skin neoplasm|SKIN TUMORS|Tumour of skin|Dermatological tumors|Neoplasm of skin|Tumor of skin|skin tumor|Skin tumors|Neoplasm, Skin|Skin Neoplasm|Skin--Tumors|NEOPLASM SKIN|Skin tumour|skin tumors|Tumor of the Skin|tumor of skin|Cutaneous tumor|Neoplasm of the skin|tumors skin|Neoplasm of the Skin|Skin Tumor|skin tumour|Cutaneous neoplasm|skin neoplasms|Neoplasms, Skin|Neoplasm of Skin|SKIN TUMOR|Skin tumor|Skin Neoplasms|Cutaneous tumour|Tumor of Skin|skin tumours|Neoplasia of the skin | Skin Neoplasms |
C0354474 | null | Plendil 10 MG 24HR Extended Release Oral Tablet|24 HR Plendil 10 MG Extended Release Oral Tablet|Plendil 10 MG 24 HR Extended Release Oral Tablet | 24 HR Felodipine 10 MG Extended Release Oral Tablet [Plendil] |
C0354474 | null | Plendil 10 MG 24HR Extended Release Oral Tablet|24 HR Plendil 10 MG Extended Release Oral Tablet|Plendil 10 MG 24 HR Extended Release Oral Tablet | 24 HR Felodipine 10 MG Extended Release Oral Tablet [Plendil] |
C0354474 | null | Plendil 10 MG 24HR Extended Release Oral Tablet|24 HR Plendil 10 MG Extended Release Oral Tablet|Plendil 10 MG 24 HR Extended Release Oral Tablet | 24 HR Felodipine 10 MG Extended Release Oral Tablet [Plendil] |
C0263313 | null | Pemphigus foliaceus|Pemphigus, foliaceus|PF - Pemphigus foliaceous|Pemphigus foliaceous|Pemphigus foliaceus (disorder)|pemphigus foliaceous|Foliaceus, Pemphigus|pemphigus foliaceus | Pemphigus Foliaceus |
C1527383 | Isolated patches of hardened skin (scleroderma). [HPO:probinson] | Morphea|Morpheas|morphea|Morphoea|MORPHEA|morpheas|morphoea|Morphea (disorder) | Morphea |
C0027538 | A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes. | Necrobiosis lipoidica, NOS|Necrobiosis Lipoidica|Necrobiosis lipoidica|NLD - Necrobiosis lipoidica|lipoidica necrobiosis nld|Necrobiosis lipoidica (disorder)|necrobiosis lipoidica | Necrobiosis Lipoidica |
C0022415 | Tuberculosis affecting a joint. | Tuberculoses, Joint|tuberculous arthritis|joints tuberculosis|Tuberculosis of joint, NOS|Joint Tuberculosis|ARTHRITIS, TUBERCULOUS|Tuberculous Arthritis|Joint Tuberculoses|Tuberculosis, Joint|Arthritis caused by Mycobacterium tuberculosis|Tuberculous rheumatism|Tuberculosis of joint|Joints--Tuberculosis|Tuberculous arthritis|Tuberculous arthritis (disorder)|of joint tuberculosis|joint tuberculosis|Tuberculous arthropathy | Joint Tuberculosis |
C0275939 | null | Tuberculosis verrucosa cutis|Prosector's wart|Warty tuberculosis|Tuberculosis verrucosa cutis (disorder)|Verruca necrogenica | Tuberculosis verrucosa cutis |
C0023860 | A bacterial infection caused by Listeria monocytogenes. It occurs in newborns, elderly, and immunocompromised patients. The bacteria are transmitted through ingestion of contaminated food. Clinical manifestations include fever, muscle pain, respiratory distress, nausea, diarrhea, neck stiffness, irritability, seizures, and lethargy. | Listeriosis, NOS|Listeria Infection|LISTERIOSIS|listeriosis|Listeria infection|listeria monocytogenes infection|Infection by Listeria monocytogenes|Infections, Listeria|Listeriosis|Circling disease|Listeriosis (disorder)|Listerellosis|Infection caused by Listeria (disorder)|Listeria Infections|Listerioses|listeria infection|Infection caused by Listeria|Infection due to Listeria monocytogenes|Infection, Listeria | Listeriosis |
C0235752 | A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. (From Rook et al., Textbook of Dermatology, 5th ed, p483) | Port Wine Nevus|Nevus Flammeus|Port Wine Birthmark|port wine nevus|bites stork|Port-wine stain|naevus flammeus|Salmon patch naevus|stork bite|Nevus simplex|PORT WINE STAIN|Portwine naevus|portwine stains|Port-wine stain of skin (disorder)|Port-wine stain of skin|Stains, Port-Wine|Port-Wine Stains|Hemangioma flammeus|port stain wine|Port wine stain of skin|Port-wine naevus|Port Wine Stain of the Skin|Salmon Patch Nevus|Portwine nevus|PWS - Port-wine stain|Port-Wine Stain of Skin|Unna's naevus|Naevus flammeus|Port Wine Type Hemangioma|PORT-WINE STAIN|Portwine stain|Salmon patch nevus (disorder)|portwine stain|port wine stain|Port-Wine Stain|Salmon patch nevus|Unna's nevus|Stork bite|flammeus nevus|Nevus flammeus|Port-wine stain of skin, NOS|Port Wine Stain|Port-wine birthmark|Port-wine nevus|port wine birthmark|nevus flammeus|port stains wine|Port Wine Stain of Skin|port-wine birthmark|port-wine stain|Stain, Port-Wine | Port-Wine Stain |
C0275938 | null | Papulonecrotic tuberculide|Papulo-necrotic tuberculid|Papulonecrotic tuberculid|Tuberculosis papulonecrotica (disorder)|Tuberculosis papulonecrotica | Tuberculosis papulonecrotica |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.